SG11201402993XA - Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof - Google Patents
Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereofInfo
- Publication number
- SG11201402993XA SG11201402993XA SG11201402993XA SG11201402993XA SG11201402993XA SG 11201402993X A SG11201402993X A SG 11201402993XA SG 11201402993X A SG11201402993X A SG 11201402993XA SG 11201402993X A SG11201402993X A SG 11201402993XA SG 11201402993X A SG11201402993X A SG 11201402993XA
- Authority
- SG
- Singapore
- Prior art keywords
- lactic acid
- metabolism
- acid bacterium
- treatment product
- containing lactic
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title 2
- 241000894006 Bacteria Species 0.000 title 1
- 235000014655 lactic acid Nutrition 0.000 title 1
- 239000004310 lactic acid Substances 0.000 title 1
- 230000037356 lipid metabolism Effects 0.000 title 1
- 230000004060 metabolic process Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/115—Amylovorus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/145—Gasseri
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011268313 | 2011-12-07 | ||
JP2012067187 | 2012-03-23 | ||
PCT/JP2012/081597 WO2013084971A1 (fr) | 2011-12-07 | 2012-12-06 | Stimulant du metabolisme des lipides et/ou du metabolisme du sucre contenant une bacterie d'acide lactique ou produit de traitement associe |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201402993XA true SG11201402993XA (en) | 2014-09-26 |
Family
ID=48574329
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201402993XA SG11201402993XA (en) | 2011-12-07 | 2012-12-06 | Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof |
SG10201609078TA SG10201609078TA (en) | 2011-12-07 | 2012-12-06 | Lipid Metabolism And/Or Sugar Metabolism Improver Containing Lactic Acid Bacterium Or Treatment Product Thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201609078TA SG10201609078TA (en) | 2011-12-07 | 2012-12-06 | Lipid Metabolism And/Or Sugar Metabolism Improver Containing Lactic Acid Bacterium Or Treatment Product Thereof |
Country Status (11)
Country | Link |
---|---|
US (2) | US20140322172A1 (fr) |
EP (1) | EP2789340A4 (fr) |
JP (3) | JP5690416B2 (fr) |
KR (2) | KR101809695B1 (fr) |
CN (1) | CN104010648A (fr) |
AU (1) | AU2012349340B2 (fr) |
CA (1) | CA2861533C (fr) |
MY (1) | MY172363A (fr) |
PH (1) | PH12014501254A1 (fr) |
SG (2) | SG11201402993XA (fr) |
WO (1) | WO2013084971A1 (fr) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2861533C (fr) * | 2011-12-07 | 2020-07-14 | Calpis Co., Ltd. | Stimulant du metabolisme des lipides et/ou du metabolisme du sucre contenant une bacterie d'acide lactique ou produit de traitement associe |
EP2836224A4 (fr) | 2012-02-29 | 2015-12-16 | Ethicon Endo Surgery Inc | Compositions de microbiota et leurs procédés associés |
CN104797265A (zh) * | 2012-11-16 | 2015-07-22 | 可尔必思株式会社 | 含有特定的加氏乳杆菌株或其处理物的压力性肠紊乱的减轻剂 |
CA2917109C (fr) * | 2013-07-02 | 2022-11-01 | Walter H. Guenzburg | Methode de cryodessiccation de cellules encapsulees, cellules encapsulees lyophilisees, compositions contenant des cellules encapsulees lyophilisees et utilisations de telles cellules et compositions |
TW201609120A (zh) * | 2013-11-07 | 2016-03-16 | Suntory Holdings Ltd | 含乳酸菌之腸道屏障功能促進劑 |
US10507222B2 (en) * | 2014-05-29 | 2019-12-17 | Nitto Pharmaceutical Industries, Ltd. | Lactic acid bacterium and composition including said lactic acid bacterium |
JP6868562B2 (ja) | 2014-10-31 | 2021-05-19 | ペンデュラム セラピューティクス, インコーポレイテッド | 障害の微生物的処置および診断に関する方法および組成物 |
JP5703513B1 (ja) * | 2014-11-05 | 2015-04-22 | 沖縄ハム総合食品株式会社 | 新規乳酸菌株及びその乳酸菌株による発酵組成物及び醗酵エキス |
HUE057494T2 (hu) | 2015-07-20 | 2022-05-28 | Quorum Innovations Llc | Anyagok és eljárások immunválaszok és a bõr és/vagy nyálkahártya gátfunkciójának javítására |
JP2017108679A (ja) * | 2015-12-16 | 2017-06-22 | 株式会社 オヴァールリエゾン | チョコレート菓子 |
JP6961339B2 (ja) * | 2015-12-18 | 2021-11-05 | アサヒ飲料株式会社 | 微生物菌体含有飲料 |
JP6894097B2 (ja) * | 2016-06-30 | 2021-06-23 | アサヒグループホールディングス株式会社 | 腎性貧血改善用組成物 |
AU2017287989B2 (en) * | 2016-06-30 | 2024-03-14 | Asahi Group Holdings, Ltd. | Composition for use in improvement of nutritional state |
WO2019046646A1 (fr) | 2017-08-30 | 2019-03-07 | Whole Biome Inc. | Methodes et compositions pour le traitement de troubles associés au microbiome |
KR101935762B1 (ko) * | 2018-08-25 | 2019-01-04 | 김민재 | 동물 투약 보조용 조성물 및 이의 제조방법 |
JP6480630B1 (ja) * | 2018-09-26 | 2019-03-13 | アサヒグループホールディングス株式会社 | 脂肪蓄積抑制剤および血中脂質改善剤 |
CN109666615B (zh) * | 2019-02-20 | 2021-03-19 | 无限极(中国)有限公司 | 一种益生菌组合物及其应用 |
IL311104A (en) * | 2019-06-11 | 2024-04-01 | Advance Pharmaceutical Inc | Superoxide soluble fiber components |
KR102229090B1 (ko) * | 2019-07-26 | 2021-03-19 | (주)성운파마코피아 | 락토바실러스 가세리 swpm102를 포함하는 허혈성 뇌질환의 예방, 개선 또는 치료용 조성물 |
JP7364390B2 (ja) * | 2019-08-19 | 2023-10-18 | 株式会社明治 | 糖代謝改善用組成物 |
KR102271528B1 (ko) * | 2020-01-03 | 2021-07-02 | 경희대학교 산학협력단 | 유산균 파쇄체로 코팅된 스테비아 분말을 포함하는 비만 또는 당뇨 예방 및 치료용 조성물 |
CN111235058B (zh) * | 2020-02-20 | 2022-11-15 | 江苏微康生物科技有限公司 | 一种具有修复紫外损伤、缓解炎症、预防皮肤光老化作用的短双歧杆菌及其制备方法和应用 |
KR102128098B1 (ko) * | 2020-03-23 | 2020-06-30 | 주식회사 종근당바이오 | 락토바실러스 델브루키 subsp. 락티스 CKDB001 균주, 및 이를 포함하는 비알코올성 지방간의 예방, 개선, 또는 치료용 조성물 |
KR102257130B1 (ko) * | 2020-06-16 | 2021-05-28 | 주식회사 엠디헬스케어 | 락토바실러스 파라카세이 유래 소포를 포함하는 신경질환 또는 정신질환 예방 또는 치료용 조성물 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61109729A (ja) | 1984-11-05 | 1986-05-28 | Advance Res & Dev Co Ltd | コレステロ−ル低下剤 |
JPS61271223A (ja) * | 1985-05-24 | 1986-12-01 | Biofuerumin Seiyaku Kk | 血中脂質改善剤 |
JP3359827B2 (ja) * | 1996-10-29 | 2002-12-24 | 株式会社ヤクルト本社 | 脂質代謝改善剤及びそれを含有する食品 |
ATE169456T1 (de) * | 1996-12-23 | 1998-08-15 | Sitia Yomo Spa | Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung |
JP3777296B2 (ja) | 2000-09-04 | 2006-05-24 | 明治製菓株式会社 | 乳酸菌によるコレステロールの低減若しくは除去方法 |
JP2003306436A (ja) | 2002-02-15 | 2003-10-28 | Snow Brand Milk Prod Co Ltd | 血清コレステロール上昇抑制剤 |
WO2004017896A2 (fr) | 2002-08-21 | 2004-03-04 | Merck & Co., Inc. | Traitement combine faisant intervenir un double agoniste de ppar alpha/gamma et un recepteur de type i d'angiotensine ii |
US7319170B2 (en) | 2003-01-17 | 2008-01-15 | Merck & Co., Inc. | N-cyclohexylaminocarbonyl benzensulfonmide derivatives |
JP5025930B2 (ja) * | 2005-09-13 | 2012-09-12 | 株式会社桃屋 | ラクトバチルス・プランタラムの菌体を有効成分とする体脂肪率低減剤 |
JP4336992B2 (ja) | 2006-01-20 | 2009-09-30 | 日清食品ホールディングス株式会社 | 血中コレステロール低減作用を有する新規乳酸菌 |
JP2007284260A (ja) * | 2006-04-12 | 2007-11-01 | Sumco Techxiv株式会社 | シリコン単結晶の製造方法 |
JP2007284360A (ja) | 2006-04-13 | 2007-11-01 | Mitsukan Group Honsha:Kk | 乳酸菌由来のppar依存的遺伝子転写活性化組成物 |
KR101355770B1 (ko) * | 2006-05-31 | 2014-02-03 | 가부시키가이샤 메이지 | 면역조절 활성이 높은 유산균의 배양법 |
JP5247012B2 (ja) | 2006-07-25 | 2013-07-24 | 雪印メグミルク株式会社 | 脂肪肝抑制剤 |
ITMI20062363A1 (it) * | 2006-12-06 | 2008-06-07 | Aat Advanced Analytical Technology | Ceppi di lattobacilli probiotici che persistono nell'intestino e ne modulano i recettori di mucosa |
JP2008214253A (ja) | 2007-03-02 | 2008-09-18 | Snow Brand Milk Prod Co Ltd | 内臓脂肪減少剤 |
US20130029906A1 (en) * | 2009-12-04 | 2013-01-31 | Eric Simard | Method of regulating ppar, obesity related pathways and their associated metabolic impact |
EP2581092B2 (fr) * | 2010-06-08 | 2020-03-11 | Asahi Group Holdings, Ltd. | Agent améliorant le métabolisme des lipides |
JP2012067187A (ja) | 2010-09-24 | 2012-04-05 | Riso Kagaku Corp | 非水系インクジェットインク |
CA2861533C (fr) * | 2011-12-07 | 2020-07-14 | Calpis Co., Ltd. | Stimulant du metabolisme des lipides et/ou du metabolisme du sucre contenant une bacterie d'acide lactique ou produit de traitement associe |
CN104797265A (zh) | 2012-11-16 | 2015-07-22 | 可尔必思株式会社 | 含有特定的加氏乳杆菌株或其处理物的压力性肠紊乱的减轻剂 |
JP2014165231A (ja) * | 2013-02-22 | 2014-09-08 | Fujitsu Ltd | 電子部品ユニット及び固定構造 |
-
2012
- 2012-12-06 CA CA2861533A patent/CA2861533C/fr active Active
- 2012-12-06 KR KR1020177024273A patent/KR101809695B1/ko active IP Right Grant
- 2012-12-06 JP JP2013548286A patent/JP5690416B2/ja active Active
- 2012-12-06 CN CN201280059978.4A patent/CN104010648A/zh active Pending
- 2012-12-06 SG SG11201402993XA patent/SG11201402993XA/en unknown
- 2012-12-06 WO PCT/JP2012/081597 patent/WO2013084971A1/fr active Application Filing
- 2012-12-06 AU AU2012349340A patent/AU2012349340B2/en active Active
- 2012-12-06 SG SG10201609078TA patent/SG10201609078TA/en unknown
- 2012-12-06 KR KR1020147018122A patent/KR20150000867A/ko active Search and Examination
- 2012-12-06 US US14/363,150 patent/US20140322172A1/en not_active Abandoned
- 2012-12-06 MY MYPI2014001658A patent/MY172363A/en unknown
- 2012-12-06 EP EP12855562.0A patent/EP2789340A4/fr not_active Withdrawn
-
2014
- 2014-06-04 PH PH12014501254A patent/PH12014501254A1/en unknown
- 2014-08-14 JP JP2014165231A patent/JP5690435B2/ja active Active
-
2015
- 2015-01-30 JP JP2015017278A patent/JP6165185B2/ja active Active
-
2017
- 2017-01-18 US US15/408,722 patent/US10245291B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR101809695B1 (ko) | 2017-12-15 |
MY172363A (en) | 2019-11-21 |
WO2013084971A1 (fr) | 2013-06-13 |
JP5690416B2 (ja) | 2015-03-25 |
JP6165185B2 (ja) | 2017-07-19 |
EP2789340A1 (fr) | 2014-10-15 |
EP2789340A4 (fr) | 2015-07-22 |
CA2861533A1 (fr) | 2013-06-13 |
JPWO2013084971A1 (ja) | 2015-04-27 |
US10245291B2 (en) | 2019-04-02 |
US20170119828A1 (en) | 2017-05-04 |
SG10201609078TA (en) | 2016-12-29 |
CA2861533C (fr) | 2020-07-14 |
JP5690435B2 (ja) | 2015-03-25 |
CN104010648A (zh) | 2014-08-27 |
AU2012349340A1 (en) | 2014-07-24 |
KR20170104629A (ko) | 2017-09-15 |
PH12014501254A1 (en) | 2014-09-08 |
AU2012349340B2 (en) | 2015-11-05 |
JP2015108010A (ja) | 2015-06-11 |
US20140322172A1 (en) | 2014-10-30 |
KR20150000867A (ko) | 2015-01-05 |
JP2014237705A (ja) | 2014-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201609078TA (en) | Lipid Metabolism And/Or Sugar Metabolism Improver Containing Lactic Acid Bacterium Or Treatment Product Thereof | |
EP2705140B8 (fr) | Nouvelles bactéries d'acide lactique et compositions les contenant | |
IL228875A0 (en) | Nutritional products containing human milk uglysaccharide and methods for their production | |
HK1207110A1 (en) | Use of lactic acid bacteria for preparing fermented food products with increased natural sweetness | |
EP2675899A4 (fr) | Biosynthèse d'oligosaccharides de lait humain dans des bactéries manipulées | |
GB201117313D0 (en) | Bacterium for use in medicine | |
LT2632277T (lt) | Pieno produktas ir gamybos būdas | |
HRP20190499T1 (hr) | Proizvod koji sadrži bakterije mliječne kiseline i sušilo | |
EP2757147A4 (fr) | Appareil de production d'une solution sucrée et système de production d'une solution sucrée | |
ZA201408583B (en) | Food hygiene method and food product | |
GB201120966D0 (en) | Confectionery products and their manufacture | |
EP2697389A4 (fr) | Régulation du métabolisme du glucose par la lipocaline 2 exprimée par les ostéoblastes | |
HK1201030A1 (en) | Synbiotic food composition containing tagatose and probiotic lactic acid bacteria | |
EP2528612A4 (fr) | Procedes de traitement de troubles du metabolisme du glucose | |
EP2528614A4 (fr) | Méthodes de traitement de troubles du métabolisme du glucose | |
EP2523730A4 (fr) | Méthodes de traitement des troubles du métabolisme du glucose | |
GB2525526B (en) | Food hygiene method and food product | |
AU2011901521A0 (en) | Treatment of abnormalities of glucose metabolism 2 | |
TWM386837U (en) | Improved structure of refrigerating and displaying cabinet for commercial products | |
GB201302086D0 (en) | Fermentation methods and their products | |
GB201114177D0 (en) | Food product and process |